Oncology
ASCO 2026: Three ADC approvals in five days, with Ken Keller...
At ASCO 26, Daiichi Sankyo leaders Ken Keller and John Tsai chatted with pharmaphorum about their big year of oncology launches, halfway in.
Market Access
Why 70% of pharma partnership spend misses patients
Finding a start-up or building an app is the cheap part; combining capabilities into something that scales across markets is the expensive part.
Oncology
ASCO 2026: Can a blood test spot cancer early? with Dr Peter...
Dr Peter Sasieni, co-investigator for the NHS Galleri trial, discusses advances in population-level blood screening for early cancer detection.
R&D
Women in STEM: Overcoming exclusionary workplace culture
pharmaphorum speaks with Thermo Fisher Scientific's Tina Liedtky about women in life sciences and leadership.
Oncology
CAR-T has a geography problem
The gap between what CAR-T can do and who can actually get it is the defining challenge of this field right now.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
